Lista de obras -

Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain Model

artículo científico publicado en 2018

Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats

artículo científico publicado en 2015

Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain

artículo científico publicado en 2016

Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine

artículo científico publicado en 2016

Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model

artículo científico publicado en 2015

Botulinum Toxin Type A-A Modulator of Spinal Neuron-Glia Interactions under Neuropathic Pain Conditions

artículo científico publicado en 2018

CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain

artículo científico publicado en 2020

Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia

scientific article published on 16 April 2019

Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model—In Vivo and In Vitro Study

artículo científico publicado en 2021

Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses

artículo científico publicado en 2020

Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain

Dataset of botulinum toxin A influence on interleukins under neuropathy

artículo científico publicado en 2016

Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain

artículo científico publicado en 2014

Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain

artículo científico publicado en 2009

Direct and indirect pharmacological modulation of CCL2/CCR2 pathway results in attenuation of neuropathic pain - In vivo and in vitro evidence

artículo científico publicado en 2016

Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model

artículo científico publicado en 2015

Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats

artículo científico publicado en 2013

Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain

artículo científico publicado en 2014

IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model

artículo científico publicado en 2015

Importance of glial activation in neuropathic pain

artículo científico

Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia

artículo científico publicado en 2014

Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine.

artículo científico publicado en 2018

Involvement of microglial cells in the antinociceptive effects of metamizol in a mouse model of neuropathic pain

scientific article published on 26 September 2018

Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model

artículo científico publicado en 2014

Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model

artículo científico publicado en 2018

Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors.

artículo científico publicado en 2018

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia – Evidence from in vivo and in vitro studies

article

Mechanisms and pharmacology of diabetic neuropathy - experimental and clinical studies

artículo científico

Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain

artículo científico publicado en 2020

Microglial Inhibition Influences XCL1/XCR1 Expression and Causes Analgesic Effects in a Mouse Model of Diabetic Neuropathy

artículo científico publicado en 2016

Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain

artículo científico publicado en 2014

Minocycline influences the anti-inflammatory interleukins and enhances the effectiveness of morphine under mice diabetic neuropathy

artículo científico publicado en 2013

Minocycline prevents dynorphin-induced neurotoxicity during neuropathic pain in rats

artículo científico publicado en 2014

Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain

artículo científico publicado en 2009

Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain

artículo científico publicado en 2022

Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies

artículo científico

Neuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems

artículo científico publicado en 2020

PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy

artículo científico publicado en 2015

Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy

artículo científico publicado en 2015

Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain

artículo científico publicado en 2016

Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury

artículo científico publicado en 2019

Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model

scholarly article by Ewelina Rojewska et al published 2018 in Frontiers in Pharmacology

Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies

scientific article published on 01 August 2018

Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model

artículo científico publicado en 2015

Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model

artículo científico publicado en 2017

Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics

artículo científico publicado en 2014

The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives

artículo científico publicado en 2021

The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats

artículo científico publicado en 2017

The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord

artículo científico publicado en 2010

The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain

article

The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathy

artículo científico publicado en 2015

Treatment with a carbon monoxide-releasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats

artículo científico publicado en 2015

Zaprinast diminished pain and enhanced opioid analgesia in a rat neuropathic pain model

scientific article published on 10 September 2018

Lista de obras de

Alterations in the Activity of Spinal and Thalamic Opioid Systems in a Mice Neuropathic Pain Model

Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats

Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain

Blockade of IL-18 signaling diminished neuropathic pain and enhanced the efficacy of morphine and buprenorphine

Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model

Botulinum Toxin Type A-A Modulator of Spinal Neuron-Glia Interactions under Neuropathic Pain Conditions

CCR4 antagonist (C021) influences the level of nociceptive factors and enhances the analgesic potency of morphine in a rat model of neuropathic pain

Chemokines CCL2 and CCL7, but not CCL12, play a significant role in the development of pain-related behavior and opioid-induced analgesia

Comparison of the Effects of Chemokine Receptors CXCR2 and CXCR3 Pharmacological Modulation in Neuropathic Pain Model—In Vivo and In Vitro Study

Comparison of the beneficial effects of RS504393, maraviroc and cenicriviroc on neuropathic pain-related symptoms in rodents: behavioral and biochemical analyses

Dataset of (±)-NBI-74330 (CXCR3 antagonist) influence on chemokines under neuropathic pain

Dataset of botulinum toxin A influence on interleukins under neuropathy

Delta-opioid receptor analgesia is independent of microglial activation in a rat model of neuropathic pain

Differential activation of spinal microglial and astroglial cells in a mouse model of peripheral neuropathic pain

Direct and indirect pharmacological modulation of CCL2/CCR2 pathway results in attenuation of neuropathic pain - In vivo and in vitro evidence

Effects of chronic doxepin and amitriptyline administration in naïve mice and in neuropathic pain mice model

Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats

Expression profiling of genes modulated by minocycline in a rat model of neuropathic pain

IL-1 receptor antagonist improves morphine and buprenorphine efficacy in a rat neuropathic pain model

Importance of glial activation in neuropathic pain

Inhibition of intracellular signaling pathways NF-κB and MEK1/2 attenuates neuropathic pain development and enhances morphine analgesia

Involvement of Macrophage Inflammatory Protein-1 Family Members in the Development of Diabetic Neuropathy and Their Contribution to Effectiveness of Morphine.

Involvement of microglial cells in the antinociceptive effects of metamizol in a mouse model of neuropathic pain

Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model

Kynurenic acid and zaprinast diminished CXCL17-evoked pain-related behaviour and enhanced morphine analgesia in a mouse neuropathic pain model

Lipopolysaccharide from Rhodobacter sphaeroides (TLR4 antagonist) attenuates hypersensitivity and modulates nociceptive factors.

Maraviroc reduces neuropathic pain through polarization of microglia and astroglia – Evidence from in vivo and in vitro studies

Mechanisms and pharmacology of diabetic neuropathy - experimental and clinical studies

Metamizole relieves pain by influencing cytokine levels in dorsal root ganglia in a rat model of neuropathic pain

Microglial Inhibition Influences XCL1/XCR1 Expression and Causes Analgesic Effects in a Mouse Model of Diabetic Neuropathy

Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain

Minocycline influences the anti-inflammatory interleukins and enhances the effectiveness of morphine under mice diabetic neuropathy

Minocycline prevents dynorphin-induced neurotoxicity during neuropathic pain in rats

Minocycline reduces the injury-induced expression of prodynorphin and pronociceptin in the dorsal root ganglion in a rat model of neuropathic pain

Mirogabalin Decreases Pain-like Behaviours and Improves Opioid and Ketamine Antinociception in a Mouse Model of Neuropathic Pain

Neuronal and immunological basis of action of antidepressants in chronic pain - clinical and experimental studies

Neuropathic Pain Dysregulates Gene Expression of the Forebrain Opioid and Dopamine Systems

PD98059 Influences Immune Factors and Enhances Opioid Analgesia in Model of Neuropathy

Parthenolide Relieves Pain and Promotes M2 Microglia/Macrophage Polarization in Rat Model of Neuropathy

Participation of pro- and anti-nociceptive interleukins in botulinum toxin A-induced analgesia in a rat model of neuropathic pain

Pharmacological Blockade of Spinal CXCL3/CXCR2 Signaling by NVP CXCR2 20, a Selective CXCR2 Antagonist, Reduces Neuropathic Pain Following Peripheral Nerve Injury

Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model

Pharmacological blockade of CXCR3 by (±)-NBI-74330 reduces neuropathic pain and enhances opioid effectiveness - Evidence from in vivo and in vitro studies

Pharmacological kynurenine 3-monooxygenase enzyme inhibition significantly reduces neuropathic pain in a rat model

Spinal CCL1/CCR8 signaling interplay as a potential therapeutic target - Evidence from a mouse diabetic neuropathy model

Synthesis and biological evaluation of compact, conformationally constrained bifunctional opioid agonist - neurokinin-1 antagonist peptidomimetics

The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives

The RS504393 Influences the Level of Nociceptive Factors and Enhances Opioid Analgesic Potency in Neuropathic Rats

The effect of botulinum neurotoxin A on sciatic nerve injury-induced neuroimmunological changes in rat dorsal root ganglia and spinal cord

The influence of microglia activation on the efficacy of amitriptyline, doxepin, milnacipran, venlafaxine and fluoxetine in a rat model of neuropathic pain

The role of some chemokines from the CXC subfamily in a mouse model of diabetic neuropathy

Treatment with a carbon monoxide-releasing molecule (CORM-2) inhibits neuropathic pain and enhances opioid effectiveness in rats

Zaprinast diminished pain and enhanced opioid analgesia in a rat neuropathic pain model